“Exfoliated dermatitis and hepatitis to first line anti-tubercular therapy with treatment of drug-sensitive tuberculosis with second line anti-tubercular therapy: a roller coaster ride”, Chest Dis Rep, vol. 12, no. 1, Jun. 2024, doi: 10.4081/cdr.12.12626.